An open label, prospective, multicenter trial, on the effect of anti-TNF alpha Chimeric monoclonal antibody (Infliximab, Remicade) on the inflammatory and fibrous lesions in patients with intestinal Crohn's Disease. An open label, prospective, multicenter trial, on the effect of anti-TNF alpha Chimeric monoclonal a ...
An open label, prospective, multicenter trial, on the effect of anti-TNF alpha Chimeric monoclonal antibody (Infliximab, Remicade) on the inflammatory and fibrous lesions in patients with intestinal Crohn's Disease. An open label, prospective, multicenter trial, on the effect of anti-TNF alpha Chimeric monoclonal a ...